Dipeptidyl peptidase-4 inhibitors and osteoporosis

J Chin Med Assoc. 2022 Sep 1;85(9):889-890. doi: 10.1097/JCMA.0000000000000775. Epub 2022 Jul 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
  • Humans
  • Osteoporosis* / drug therapy

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases